Physician profile
Peter V Sundwall
NPI 1558470641
$331.39
in general payments reported to CMS, 2019-2025
9 companies · $77.88 in 2025
The $77.88 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.01 · 2022: $17.85 · 2023: $131 · 2024: $16.99 · 2025: $77.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $120.54 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Quidel Corporation | $48.71 | 2021 | |
| Lilly USA, LLC | $33.68 | 2023-2025 | Mounjaro |
| Globus Medical, INC. | $31.52 | 2025 | Senza |
| Novo Nordisk INC | $29.14 | 2025 | Wegovy |
| Supernus Pharmaceuticals, INC. | $20.92 | 2023 | Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $17.85 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.61 | 2023 | Quviviq |
| Organon LLC | $11.42 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sundwall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.